These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7054288)

  • 1. Mouse brain: an immunologically privileged site for natural resistance against lymphoma cells.
    Circolo A; Bianchi R; Nardelli B; Rivosecchi-Merletti P; Bonmassar E
    J Immunol; 1982 Feb; 128(2):556-62. PubMed ID: 7054288
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental analysis of intracerebral natural resistance against H-2+ and H-2- lymphomas grafted into the brain].
    Yamasaki T; Kikuchi H; Yamashita J; Ljunggren HG; Karre K; Klein G
    No Shinkei Geka; 1989 Aug; 17(8):717-23. PubMed ID: 2586713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lymphoma growth in the spleen and liver of lethally irradiated mice.
    Iorio A; Campanile F; Neri M; Spreafico F; Goldin A; Bonmassar E
    J Immunol; 1978 May; 120(5):1679-85. PubMed ID: 659871
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological response in the mouse brain: I. Transplantation immunity to mouse lymphoma graft.
    Keyaki A; Handa H; Yamashita J; Kuribayashi K; Masuda T
    Nihon Geka Hokan; 1988 May; 57(3):191-201. PubMed ID: 3248016
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice.
    Schirrmacher V
    Invasion Metastasis; 1981; 1(1):4-21. PubMed ID: 7188381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the YC8 lymphoma growth by alloimmunization with normal cells.
    Parmiani G; Sensi ML
    Transplant Proc; 1981 Dec; 13(4):1906-9. PubMed ID: 7330975
    [No Abstract]   [Full Text] [Related]  

  • 7. Radioresistant inhibition of lymphoma growth in congenitally athymic (nude) mice.
    Campanile F; Crino L; Bonmassar E; Houchens D; Goldin A
    Cancer Res; 1977 Feb; 37(2):394-8. PubMed ID: 832264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological response in the mouse brain: II. Experimental immunotherapy model against transplanted mouse lymphoma in the brain.
    Keyaki A; Handa H; Yamashita J; Kuribayashi K; Masuda T
    Nihon Geka Hokan; 1988 May; 57(3):202-14. PubMed ID: 3266837
    [No Abstract]   [Full Text] [Related]  

  • 9. On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras.
    Zinkernagel RM; Althage A; Callahan G; Welsh RM
    J Immunol; 1980 May; 124(5):2356-65. PubMed ID: 6444970
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclical changes in susceptibility of a myeloma tumor (LPC-1) to immune destruction. II. Periodic fluctuations during growth in normal and nude mice and in culture.
    Hale AH; Celis E; Russell JH; Eisen HN
    J Immunol; 1979 Mar; 122(3):959-64. PubMed ID: 312829
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth of P511 mastocytoma cells in BALB/c mouse brain elicits CTL response without tumor elimination: a new tumor model for regional central nervous system immunity.
    Gordon LB; Nolan SC; Cserr HF; Knopf PM; Harling-Berg CJ
    J Immunol; 1997 Sep; 159(5):2399-408. PubMed ID: 9278331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific graft-versus-host nonreactivity of lymphoid cells from irradiation chimeras.
    Norin AJ; Emeson EE; Veith FJ
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1241-4. PubMed ID: 7268889
    [No Abstract]   [Full Text] [Related]  

  • 13. Variation in histocompatibility antigen expression on murine tumors: differences in expression and immunogenicity of H-2K region-coded unique antigens.
    Imamura M; Martin WJ
    J Immunol; 1982 Aug; 129(2):877-81. PubMed ID: 7086147
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ultradian fluctuations in the natural antitumor resistance of mice undergoing transplantation and chemical carcinogenesis].
    Suslov AP; Riabykh TP; Slavina EG; Kasatkina NN; Leĭpunskaia IL
    Tsitologiia; 1987 Jan; 29(1):79-85. PubMed ID: 3564161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected reaction of anti-H-2d serum with thymic lymphoma cells derived from transgenic B6-H-2b TCR anti-HY/Db mice.
    Matuszyk J; Zioło E; Kobzdej M; Strzadala L
    Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):103-7. PubMed ID: 8915513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new minor histocompatibility locus linked to H-3.
    Click RE; Schneider D; Roopenian DC
    J Immunol; 1981 Jun; 126(6):2378-81. PubMed ID: 7229381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Origin and function of suppressor macrophages in myeloma.
    Kennard J; Zolla-Pazner S
    J Immunol; 1980 Jan; 124(1):268-73. PubMed ID: 6965292
    [No Abstract]   [Full Text] [Related]  

  • 18. [Appearance of new transplantation antigens in tumor cells treated with RNA].
    Nikolin VP; Il'nitskaia SI; Gruntenko EV; Tomsons VP
    Eksp Onkol; 1984; 6(1):42-7. PubMed ID: 6209090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.
    Ljunggren HG; Kärre K
    J Exp Med; 1985 Dec; 162(6):1745-59. PubMed ID: 3877776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Source of tumor cells influences their immune recognition by H-2-matched mice.
    Forni G; Varesio L; Giovarelli M; Landolfo S
    Transplantation; 1979 Jun; 27(6):433-5. PubMed ID: 462530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.